THE UNREGULATED RECOMMENDED VOLUNTARY OFFER TO THE SHAREHOLDERS OF EVERFUEL A/S HAS BECOME UNCONDITIONAL – FARO BIDCO APS HAS BECOME THE MAJORITY SHAREHOLDER
Reading Time: 8 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS
1win and David Warner Launch Charitable #1win1000hits Challenge
Reading Time: < 1 minute 1win, in partnership with cricket star David Warner, is excited to launch the #1win1000hits challenge — a charitable flashmob aimed at raising awareness of social issues and promoting support for those in need. Warner started the challenge by posting a
Director/PDMR Shareholding – AstraZeneca
Reading Time: 2 minutes 15 November 2024 10:00 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that it was notified on 14 November 2024 that Pascal Soriot, Chief Executive Officer, purchased 20,000 of the Company’s ordinary shares of $0.25 each (Ordinary
Bulletin from the Extraordinary General Meeting of Metacon AB (publ)
Reading Time: 3 minutes Metacon AB (publ), corporate identity number 556724-1616 (the “Company”), has held an Extraordinary General Meeting today, 15 November 2024 at 10:00 CET, at Advokatfirman Schjødt, Hamngatan 27, Stockholm. The Extraordinary General Meeting made the following resolutions. Amendments of the articles of
Lehto Group Plc, inside information: Information about Lehto’s energy construction business and the company’s intention to apply for the transfer of share trading to the First North Growth Market
Reading Time: 4 minutes Lehto Group PlcInsider information15 November 2024 at 11.00 (Finnish time) Lehto Group Oyj (“Lehto” or “Company”) has previously announced on 29 May 2024 that it will focus its business on real estate energy solutions and electricity storages (“Energy construction business”). The
EQL Pharma’s CBDO increases his holding in the company
Reading Time: 2 minutes EQL Pharma’s Chief Business Development Officer (CBDO), Carl Lindgren, increases his shareholding in the company. On November 14th, Carl Lindgren has bought 10,000 shares in the Company at an average price of SEK 60.00, a transaction totalling SEK 600,000. The trades were
Well-executed clinical introduction of EndoDrill[®] GI at Sahlgrenska University Hospital in Sweden
Reading Time: 2 minutes The cancer diagnostics company BiBBInstruments AB (“BiBB” and the “Company”), the developer of EndoDrill®, the world’s first market-cleared electric-driven biopsy instrument for endoscopy, announces that the first clinical tissue sampling procedures with EndoDrill® GI at Sahlgrenska University Hospital in Gothenburg have been successfully
Respiratorius CEO to BioStock: “We continue to reduce risk in the project”
Reading Time: < 1 minute Fri, Nov 15, 2024 08:15 CET Report this content The partnering process continues for Respiratorius, which recently released the report for the third quarter. The US patent has been approved and the focus is now on refining the
Panoro Energy – Group Operations Update: Dussafu Production Reaches 40,000 bopd
Reading Time: 5 minutes Oslo, 15 November 2024 – Panoro Energy ASA (“Panoro” or the “Company”) is pleased to provide an operations update in advance of its Q3 2024 results which are scheduled for release on 20 November 2024. At the Dussafu Marin Permit offshore
Tokmanni Group’s Business Review for January–September 2024: Revenue increased and EBIT improved in the third quarter
Reading Time: 23 minutes Tokmanni Group Corporation Business Review Unaudited 15 November 2024 at 8:00 THIRD QUARTER 2024 HIGHLIGHTS Tokmanni Group’s revenue grew by 14.3% (23.6%) and was EUR 416.3 million (364.3) Like-for-like revenue increased by 0.8% (0.3%) Comparable gross profit was EUR 148.3 million